NVTS vs. CLOV, HLLY, MVST, HYZN, CANO, WOLF, NSSC, SHLS, BELFA, and ICHR
Should you be buying Navitas Semiconductor stock or one of its competitors? The main competitors of Navitas Semiconductor include Clover Health Investments (CLOV), Holley (HLLY), Microvast (MVST), Hyzon Motors (HYZN), Cano Health (CANO), Wolfspeed (WOLF), Napco Security Technologies (NSSC), Shoals Technologies Group (SHLS), Bel Fuse (BELFA), and Ichor (ICHR).
Clover Health Investments (NASDAQ:CLOV) and Navitas Semiconductor (NASDAQ:NVTS) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their valuation, analyst recommendations, risk, media sentiment, dividends, earnings, institutional ownership, community ranking and profitability.
Navitas Semiconductor has lower revenue, but higher earnings than Clover Health Investments. Navitas Semiconductor is trading at a lower price-to-earnings ratio than Clover Health Investments, indicating that it is currently the more affordable of the two stocks.
Clover Health Investments has a net margin of -8.63% compared to Clover Health Investments' net margin of -97.75%. Clover Health Investments' return on equity of -21.22% beat Navitas Semiconductor's return on equity.
19.8% of Clover Health Investments shares are held by institutional investors. Comparatively, 46.1% of Navitas Semiconductor shares are held by institutional investors. 22.3% of Clover Health Investments shares are held by insiders. Comparatively, 31.8% of Navitas Semiconductor shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
Clover Health Investments currently has a consensus target price of $1.50, indicating a potential downside of 13.29%. Navitas Semiconductor has a consensus target price of $7.41, indicating a potential upside of 93.58%. Given Clover Health Investments' stronger consensus rating and higher probable upside, analysts clearly believe Navitas Semiconductor is more favorable than Clover Health Investments.
Clover Health Investments has a beta of 2.11, suggesting that its share price is 111% more volatile than the S&P 500. Comparatively, Navitas Semiconductor has a beta of 2.42, suggesting that its share price is 142% more volatile than the S&P 500.
In the previous week, Clover Health Investments had 2 more articles in the media than Navitas Semiconductor. MarketBeat recorded 5 mentions for Clover Health Investments and 3 mentions for Navitas Semiconductor. Navitas Semiconductor's average media sentiment score of 0.72 beat Clover Health Investments' score of 0.47 indicating that Clover Health Investments is being referred to more favorably in the media.
Navitas Semiconductor received 2 more outperform votes than Clover Health Investments when rated by MarketBeat users. Likewise, 41.82% of users gave Navitas Semiconductor an outperform vote while only 39.62% of users gave Clover Health Investments an outperform vote.
Summary
Navitas Semiconductor beats Clover Health Investments on 11 of the 18 factors compared between the two stocks.
Get Navitas Semiconductor News Delivered to You Automatically
Sign up to receive the latest news and ratings for NVTS and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding NVTS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Navitas Semiconductor Competitors List
Related Companies and Tools
